EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 25-Oct-2026 19:17 ET (25-Oct-2026 23:17 GMT/UTC)

New USF study identifies promising strategy to protect the heart in Duchenne muscular dystrophy

University of South Florida
Peer-Reviewed Publication

Researchers at the University of South Florida USF Health Morsani College of Medicine have identified a potential pathway that could protect cardiac function in people with Duchenne muscular dystrophy, a progressive and fatal genetic disease that weakens the body’s muscles.

Journal: Molecular Therapy

Lurie Children’s Program helps pediatricians gain independent expertise to treat more kids with depression and anxiety, study finds

Ann & Robert H. Lurie Children's Hospital of Chicago
Peer-Reviewed Publication

Pediatricians who participated in the collaborative mental health program at Ann & Robert H. Lurie Children’s Hospital of Chicago were more likely to diagnose and treat anxiety and depression in kids without reliance on additional support from specialists, according to a study published in Academic Pediatrics. Findings suggest that the program – called Mood, Anxiety, ADHD Collaborative Care (MAACC) – successfully prepares pediatricians to manage these conditions independently, so that more children can access care despite the ongoing shortage of pediatric mental health professionals.

Journal: Academic Pediatrics

JMIR news: developments in E-nose diagnosis, rare disease research, and AI tools in medical education

JMIR Publications
Reports and Proceedings

JMIR Publications released two feature News and Perspectives articles covering health tech research developments, and one investigating the rising use of AI in medical education.

Journal: Journal of Medical Internet Research

Postshortage compounded GLP-1 RA market in 2 states with potentially high demand

JAMA Network
Peer-Reviewed Publication

The findings of this study show that, after the end of the semaglutide and tirzepatide shortages, compounding facilities have continued to manufacture glucagon-like peptide-1 receptor agonists (GLP-1 RAs) with added ingredients. Compounded GLP-1 RA sourcing is diverse but includes facilities without licenses to perform sterile compounding or that have been subject to recent disciplinary action, posing clinical and regulatory challenges.

Journal: JAMA Health Forum

The Journal of Nuclear Medicine ahead-of-print tip sheet: July 17, 2026

Society of Nuclear Medicine and Molecular Imaging
Peer-Reviewed Publication

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.

Journal: Journal of Nuclear Medicine

DNA blood test improves patient selection for radiopharmaceutical therapy in prostate cancer

Society of Nuclear Medicine and Molecular Imaging
Peer-Reviewed Publication

A noninvasive DNA blood test can identify metastatic castration-resistant prostate cancer (mCRPC) patients who are most likely to benefit from ²²³Ra radiopharmaceutical therapy and monitor their progress throughout treatment, according to new research published in the July issue of The Journal of Nuclear Medicine. Incorporating this new approach to DNA profiling into clinical practice has the potential to refine patient selection, enable early detection of treatment resistance, and optimize personalized management for prostate cancer patients.

Journal: Journal of Nuclear Medicine

Study shows where women live can shape heart health for decades

Harvard Pilgrim Health Care Institute
Peer-Reviewed Publication

Women who live in disadvantaged neighborhoods face worse heart health and experience faster decline as they approach menopause, according to a long-term study led by the Harvard Pilgrim Health Care Institute.

Journal: Circulation

Study finds some medical spas still selling compounded weight-loss drugs from pharmacies with regulatory concerns

University of Colorado Anschutz
Peer-Reviewed Publication

CU Anschutz researchers found the compounded GLP-1 market remains robust after FDA shortages ended, with some products supplied by pharmacies lacking sterile compounding licenses or with recent disciplinary histories.

Journal: JAMA Health Forum

Weekly Events | Insilico Medicine executives at CPIC: navigating the dual breakthrough of tech innovation and clinical validation in AI drug discovery

InSilico Medicine
Meeting Announcement

Dr. Alex Zhavoronkov, Founder and Co-CEO of Insilico Medicine, and Dr. Feng Ren, Co-CEO and Chief Scientific Officer, have been invited to attend the inaugural China Pioneer Innovative Drug Global Congress (CPIC 2026), which will grandly convene at the National Exhibition and Convention Center (Shanghai) from July 22 to 24. During this premier event, the two industry leaders will appear at several high-profile forums to deliver keynote speeches, sharing deep insights on how cutting-edge AI combines with "China Speed" to decode the mysteries of life and reshape the global drug R&D landscape.